Dr. Sanjay Shukla, M.D., CEO of RxMD, has been invited to be a panelist in the opening plenary session at the 10th Annual BIO Investor Forum to be held in
Dr Shukla’s session, The New Drug-Centric VC Universe—Return of the ROI, will explore recent innovative departures from traditional funding models that have served to, despite the difficult times, once again make private biotech companies attractive investments. The panel will also discuss creative approaches to reengineering the biotech drug development model.
The Forum, targeted at public and private equity investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences, will feature over 200 participating companies and will deliver a rich program featuring corporate presentations, panel debates, expert-led workshops and on-on-one investor meetings. For more information click on http://www3.bio.org/investorforum/?q=investorforum/